Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Innovative Approach to Geriatric Osteoporosis
NCT05058976Phase 4Active, not recruiting
- Start
- Sep 2021
- Primary completion
- Mar 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of romosozumab in osteoporosis. Started Sep 2021; status: active, not recruiting.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05058976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05058976.